Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramDirector, PRESIDENT AND CEOCIK 0001859453
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Fordyce MarshallDirector, PRESIDENT AND CEO |  VERAVera Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 18.5K sh | Sep 17, 2026 traded Sep 15, 2026 | |
Fordyce MarshallDirector, PRESIDENT AND CEO |
| VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan |
| SELL |
| $685K 18.5K sh |
| Sep 17, 2026 traded Sep 15, 2026 |
| 0 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $54K 18.5K sh | Sep 17, 2026 traded Sep 15, 2026 |
| 8 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $650K 18.5K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 0 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $54K 18.5K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 0 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 18.5K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 11 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $698K 18.4K sh | Jun 24, 2026 traded Jun 23, 2026 |
| 1 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,382 88 sh | Jun 24, 2026 traded Jun 23, 2026 |
| 4 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $159K 4,281 sh | May 13, 2026 traded May 12, 2026 |
| 11 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $521K 14.2K sh | May 13, 2026 traded May 12, 2026 |
| 15 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $617K 14.1K sh | Apr 15, 2026 traded Apr 14, 2026 |
| 11 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $353K 7,921 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 5 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 900 sh | Apr 15, 2026 traded Apr 14, 2026 |
| 9 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Grant or award | A | — 137.5K sh | Feb 6, 2026 traded Feb 4, 2026 |
| 17 | Fordyce MarshallDirector, PRESIDENT AND CEO | VERAVera Therapeutics, Inc. Grant or award | A | — 68.8K sh | Feb 6, 2026 traded Feb 4, 2026 |